Frontlight ResearchEarly access
Cushing's syndrome trials in United States
14 of 21 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Not yet taking people in United StatesRelacorilant in Patients With Poorly Controlled Type 2 Diabetes and Autonomous Cortisol Secretion
- Where
- San Antonio
- Age
- 18 years to 75 years
- People
- 34
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT07925801 - Phase 4Taking peopleOsilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
- Where
- Canton, Jacksonville, Weslaco
- Age
- 18 years and over
- People
- 63 worldwide
- Run by
- RECORDATI GROUP
See details and how to joinNCT07247162 · EU 2025-524649-28-00 - Early phase 1Taking peopleFET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
- Where
- Rochester
- Age
- 18 years and over
- People
- 50
- Run by
- Mayo Clinic
See details and how to joinNCT07460232 - Phase 4Taking peopleIsturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
- Where
- Baltimore
- Age
- 18 years and over
- People
- 10
- Run by
- Johns Hopkins University
See details and how to joinNCT07247058 - Phase 2Taking peopleEvaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 80
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06246357 - Phase 2Taking peopleTrial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Where
- Albany, Anderson, Atlanta, Austin, Boise, Chandler, Chapel Hill, Chicago, Cincinnati, Columbus, Dallas, Edgewater, Edgewood, Eugene, Fort Lauderdale, Fountain Valley, Greenville, Houston, Huntington Park, Lafayette, La Mesa, Lampasas, Las Vegas, Lewisville, Lincoln, Long Beach, Los Angeles, Metairie, Miami, Mission, Morehead City, Mt. Pleasant, New Orleans, New Port Richey, Northridge, Omaha, Port Charlotte, Port Orange, Rockville, Round Rock, San Antonio, San Diego, Seabrook, Springfield, Suffolk, Troy, Tucson, Vienna, Weslaco, West Chester, West Des Moines, West Jordan, Wichita, Wilmington, Winter Park
- Age
- 18 years and over
- People
- 1,500
- Run by
- Sparrow Pharmaceuticals
See details and how to joinNCT07296484 - Phase 2Taking peopleProspective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
- Where
- Bethesda
- Age
- 18 years to 80 years
- People
- 80
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT02019706 - Phase 2Taking peopleMetyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
- Where
- Rochester
- Age
- 18 years and over
- People
- 90
- Run by
- Mayo Clinic
See details and how to joinNCT07138274 - Phase 2Taking peopleDesmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
- Where
- Bethesda
- Age
- 18 years to 70 years
- People
- 140
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT06635629 - Phase 2Taking peopleFimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 20
- Run by
- University of California, Los Angeles
See details and how to joinNCT05971758 - No phaseTaking peopleDDAVP for Pituitary Adenoma
- Where
- Bethesda
- Age
- 8 years to 99 years
- People
- 22
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT04569591 - Phase 2Taking peoplePharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
- Where
- Bethesda, Cape Coral, Chicago, San Francisco, Weslaco
- Age
- 2 years to 17 years
- People
- 12 worldwide
- Run by
- RECORDATI GROUP
See details and how to joinNCT03708900 · EU 2024-516825-30-00 - No phaseTaking peopleIMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
- Where
- Dallas
- Age
- 18 years and over
- People
- 75
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07361874 - Phase 2Taking peopleImpact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
- Where
- Rochester
- Age
- 18 years and over
- People
- 15
- Run by
- Mayo Clinic
See details and how to joinNCT07104812